Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia

Alemu, Abebe; Shiferaw, Yitayal; Getnet, Gebeyaw; Yalew, Aregaw; Addis, Zelalem

doi:10.1016/s1995-7645(11)60168-5

Cited by 85 publications

(85 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…frequency was similar to that found in HIV-positive patients referred to the UFTM hospital (MG), where a 10.1% rate was found (Assis et al, 2013). However, this coccidial infection showed an even higher prevalence in immunocompromised patients from other countries, such as 53% in kidney transplant patients in Pakistan (Raja et al, 2014) and 43.6% for HIV/AIDS patients in Ethiopia (Alemu et al, 2011). In addition, studies have linked Cryptosporidium spp., among other parasites, to the development of cancer, inasmuch as it is believed that chronic inflammation of the intestinal tract due to the presence of the parasite could induce pathological disorders with adenocarcinoma genesis.…”

Section: Discussionsupporting

confidence: 80%

“…Current estimates indicate that at least a quarter of the world's population, mostly in developing countries, is chronically infected with intestinal parasites (Alemu et al, 2011). Despite sanitation improvement and hygiene education in recent decades, these infections continue to be characterized as a major cause of morbidity worldwide (Lustigman et al, 2012).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Intestinal parasites in cancer patients in the South of Brazil

et al. 2017

View full text Add to dashboard Cite

Intestinal parasitic infections in immunocompromised patients can lead to serious complications when not diagnosed and treated early. This study aimed to investigate the frequency of intestinal parasites in cancer patients undergoing chemotherapy in the South of Brazil. Three fecal samples collected from each patient (73 individuals) were processed by Ritchie and Faust techniques and submitted to specific staining methods for intestinal protozoa. A 61.6% parasite and/or commensal positivity was found. Helminths identified were Ascaris lumbricoides (33.3%), Taenia spp. (6.6%), Strongyloides stercoralis (4.4%) and Trichuris trichiura (2.2%). Among protozoans, Giardia lamblia (26.6%), Cryptosporidium spp. (13.3%) and Cystoisospora belli (4.4%) were identified. The presence of Entamoeba coli, Endolimax nana and Entamoeba hartmanni was also recorded. The results obtained warn of the importance of fecal parasitological diagnosis and the use of specific staining methods for the detection of intestinal parasites in cancer patients. These exams should be regularly requested at the patient's first clinic visit, given the high prevalence found in this study and the possible severity of such conditions for these individuals.Keywords: intestinal parasites, immunocompromised patients, cancer. Parasitos intestinais em pacientes com câncer do Sul do Brasil ResumoAs parasitoses intestinais em pacientes imunocomprometidos podem levar a graves complicações se não diagnosticadas e tratadas precocemente. Este estudo teve como objetivo investigar a frequência de parasitos intestinais em pacientes oncológicos submetidos ao tratamento quimioterápico. Foram coletadas três amostras de fezes de cada paciente, sendo processadas pelas técnicas de Ritchie e Faust e submetidas à métodos de coloração específicos para protozoários intestinais. Foi encontrada positividade de 61,6% para parasitos e/ou comensais. Os helmintos identificados foram Ascaris lumbricoides (33,3%), Taenia spp. (6,6%), Strongyloides stercoralis (4,4%) e Trichuris trichiura (2,2%). Dentre os protozoários, foram identificados Giardia lamblia (26,6%), Cryptosporidium spp. (13,3%) e Cystoisospora belli (4,4%). Também foi registrada presença de Entamoeba coli, Endolimax nana e Entamoeba hartmanni. Os resultados encontrados alertam para a importância do diagnóstico parasitológico de fezes junto à utilização de colorações específicas para parasitos intestinais em pacientes oncológicos, sendo que os mesmos deveriam ser requeridos como conduta já na primeira consulta clínica destes pacientes, dada à elevada prevalência aqui constatada e a possível severidade que tais moléstias podem acarretar nestes indivíduos.Palavras-chave: parasitos intestinais, pacientes imunocomprometidos, câncer.

show abstract

Section: Discussionsupporting

confidence: 80%

Section: Introductionmentioning

confidence: 99%

Intestinal parasites in cancer patients in the South of Brazil

et al. 2017

View full text Add to dashboard Cite

show abstract

“…This result was different from previous reports. [24][25][26] This most likely resulted from the special controlled environment and proper hygiene practices of the individuals with HIV that reduced Blastocystis infection among these children. All of the HIV-infected children received antiretroviral therapy (GPOVir-S30: lamivudine, stavudine, nevirapine) with close supervision for the drug compliance.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Risk Factors for Blastocystis Infection Among Children and Caregivers in a Child Care Center, Bangkok, Thailand

Pipatsatitpong¹,

Leelayoova²,

Mungthin³

et al. 2015

The American Society of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

Abstract. In September 2009, a cross-sectional study was conducted to evaluate parasitic infections in a child care center in Khlong Toei, Bangkok, Thailand. Of 503 children and staff members, 258 (51.3%) stool samples and questionnaires were obtained. The most common parasitic infection was Blastocystis sp. (13.6%). Blastocystis sp. subtype 3 was predominantly found (80.0%), followed by subtypes 2 (12

show abstract

“…They concluded that Blastocystis was a possible pathogenic agent in immunocompromised patients [62]. A more recent study of intestinal parasites in HIV/AIDS patients in Ethiopia showed that Blastocystis was the third most common parasite identified at 10.6% of the study population of 248 patients [63]. There were no Blastocystis infections seen in the HIV negative group.…”

Section: Introductionmentioning

confidence: 99%

Update on the pathogenic potential and treatment options for Blastocystis sp

et al. 2014

View full text Add to dashboard Cite

Although Blastocystis is one of the most common enteric parasites, there is still much controversy surrounding the pathogenicity and potential treatment options for this parasite. In this review we look at the evidence supporting Blastocystis as an intestinal pathogen as shown by numerous case studies and several in vivo studies and the evidence against. We describe the chronic nature of some infections and show the role of Blastocystis in immunocompromised patients and the relationship between irritable bowel syndrome and Blastocystis infection. There have been several studies that have suggested that pathogenicity may be subtype related. Metronidazole is the most widely accepted treatment for Blastocystis but several cases of treatment failure and resistance have been described. Other treatment options which have been suggested include paromomycin and trimethroprim- sulfamethoxazole.

show abstract

Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia

Abstract: Opportunistic parasite infections are common health problem among HIV/AIDS patients in the study area. Therefore, early detection and treatment of these parasites are important to improve the quality of life of HIV/AIDS patients.

Cited by 85 publications

References 16 publications

Intestinal parasites in cancer patients in the South of Brazil

Intestinal parasites in cancer patients in the South of Brazil

Prevalence and Risk Factors for Blastocystis Infection Among Children and Caregivers in a Child Care Center, Bangkok, Thailand

Update on the pathogenic potential and treatment options for Blastocystis sp

Contact Info

Product

Resources

About